DoorDash Announces Date and Time Change of First Quarter 2025 Financial Results and Conference Call

DoorDash Announces Date and Time Change of First Quarter 2025 Financial Results and Conference Call

SAN FRANCISCO–(BUSINESS WIRE)–
DoorDash, Inc. (NASDAQ: DASH) announced today that it has changed the date and time of the release of its first quarter 2025 financial results and related earnings conference call. The company will now report its earnings for the first quarter 2025 on Tuesday, May 6, 2025, prior to market open, and host a conference call at 5 a.m. PT / 8 a.m. ET the same day. The company previously planned to release its financial results after the U.S. financial markets closed on Wednesday, May 7, 2025, with a conference call to follow at 2 p.m. PT / 5 p.m. ET the same day.

Interested parties may register for and access the live webcast of the call at the DoorDash Investor Relations website at ir.doordash.com. Following the call, a replay will be available at the same website. Those parties who previously registered for the conference call will not need to register again for the call as a result of the date and time change.

DoorDash announces material information to the public about the company, its products and services, and other matters through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls, webcasts, the investor relations section of its website (ir.doordash.com), its blog (doordash.news), and its X account (@DoorDash) in order to achieve broad, non-exclusionary distribution of information to the public and for complying with its disclosure obligations under Regulation FD.

About DoorDash

DoorDash (NASDAQ: DASH) is one of the world’s leading local commerce platforms that helps businesses of all kinds grow and innovate, connects consumers to the best of their neighborhoods, and gives people fast, flexible ways to earn. Since its founding in 2013, DoorDash has expanded to over 30 countries, using technology and logistics to shape the future of commerce. Through its Marketplace and its Commerce Platform, DoorDash is driving economic vitality in the regions it serves worldwide.

Investor Relations

[email protected]

Press

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Other Retail Online Retail Technology Supermarket Electronic Commerce Delivery Services Apps/Applications Retail Software Restaurant/Bar Food Tech

MEDIA:

Logo
Logo

Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025

Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025

Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on May 9, 2025

NASHVILLE, Tenn.–(BUSINESS WIRE)–
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, after the market close. The Company will also post its first quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Friday, May 9, 2025, to discuss the results and provide a business update.

Conference Call Information

Participants can access the live conference call via webcast on the “Investors” page of Harrow’s website. To participate via telephone, please register in advance using this link. Upon registration, all telephone participants will receive a confirmation email with detailed instructions, including a unique dial-in number and PIN, for accessing the call. A replay of the conference call webcast will be archived on the Company’s website for one year.

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

Jamie Webb

Director of Communications and Investor Relations

[email protected]

615-733-4737

KEYWORDS: United States North America Tennessee

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Optical Medical Supplies Surgery Health FDA Clinical Trials

MEDIA:

Logo
Logo

Nexstar Media Group Declares Quarterly Cash Dividend of $1.86 Per Share

Nexstar Media Group Declares Quarterly Cash Dividend of $1.86 Per Share

IRVING, Texas–(BUSINESS WIRE)–
Nexstar Media Group, Inc. (NASDAQ: NXST) announced today that its Board of Directors declared a quarterly cash dividend of $1.86 per share of its common stock. The dividend is payable on Monday, June 2, 2025, to shareholders of record on Monday, May 19, 2025.

While the Company intends to pay regular quarterly cash dividends for the foreseeable future, all subsequent dividends will be reviewed quarterly and declared by the Board of Directors at its discretion.

About Nexstar Media Group, Inc.

Nexstar Media Group, Inc. (NASDAQ: NXST) is a leading diversified media company that produces and distributes engaging local and national news, sports and entertainment content across its television and digital platforms, including more than 316,000 hours of programming produced annually by its business units. Nexstar owns America’s largest local television broadcasting group comprised of top network affiliates, with more than 200 owned or partner stations in 116 U.S. markets reaching 220 million people. Nexstar’s national television properties include The CW, America’s fifth major broadcast network, NewsNation, our national news network providing “News for All Americans,” popular entertainment multicast networks Antenna TV and Rewind TV, and a 31.3% ownership stake in TV Food Network. The Company’s portfolio of digital assets, including its local TV station websites, The Hill and NewsNationNow.com, are collectively a Top 10 U.S. digital news and information property. For more information, please visit nexstar.tv.

Investor Contacts:

Lee Ann Gliha

Executive Vice President and Chief Financial Officer

Nexstar Media Group, Inc.

972/373-8800

Joseph Jaffoni or Jennifer Neuman

JCIR

212/835-8500 or [email protected]

Media Contact:

Gary Weitman

EVP and Chief Communications Officer

972/373-8800

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Media TV and Radio Communications Entertainment

MEDIA:

Logo
Logo

Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera

Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera

Stanford-led study included over 2,100 Signatera samples from over 200 sarcoma patients, with overall sensitivity of 89% and specificity of 100%

Leiomyosarcoma, the most common subtype in the cohort, demonstrated sensitivity of 93% and specificity of 100%

AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the results of a study led by Stanford University School of Medicine for the evaluation of Signatera, Natera’s personalized molecular residual disease (MRD) test, in patients with soft tissue and bone sarcomas. Results of the study (Utilizing Circulating Tumor DNA to Monitor Sarcoma Treatment and Recurrence) were presented at the 2025 Society of Surgical Oncology (SSO) Annual Meeting in March.

With evaluation of approximately 200 patients and more than 2,100 plasma samples across multiple distinct subtypes, this is the largest sarcoma cohort to date using personalized circulating-tumor DNA (ctDNA) monitoring. The study assessed the correlation of Signatera results with imaging, stratified by sarcoma subtype, and followed patients through treatment, disease progression, and surveillance.

Key findings included:

  • The results demonstrated excellent test performance, with overall sensitivity to recurrence of 89% and specificity of 100%.
  • In leiomyosarcoma, the most common subtype in the cohort, sensitivity was 93%, with specificity of 100%.
  • For leiomyosarcoma patients who experienced progression, ctDNA kinetics during subsequent therapy were highly correlated with treatment response (90%).

Sarcomas are a heterogeneous group of rare cancers, with more than 70 distinct histologic subtypes1, making treatment response and recurrence especially difficult to monitor through standard imaging and clinical evaluation. There are approximately 17,000 new cases of sarcoma diagnosed annually in the United States.2

“This data represents a major step forward in understanding how ctDNA monitoring can be applied across a diverse range of sarcoma subtypes,” said Beatrice J. Sun, M.D., department of surgery at Stanford University. “With the ability to noninvasively detect disease recurrence and monitor treatment response, Signatera demonstrates the potential to meaningfully improve personalized care for patients with sarcoma.”

“This is the most comprehensive dataset to date on ctDNA monitoring in sarcoma, and it shows excellent performance of Signatera in a difficult-to-monitor cancer,” said Alexey Aleshin, M.D., corporate chief medical officer and general manager of oncology at Natera. “The heterogeneity of sarcoma demands a personalized approach, and these results support Signatera’s unique ability to track disease status with precision across a broad spectrum of subtypes.”

This retrospective real-world study demonstrates the promise of Signatera as a tool to monitor disease recurrence and treatment response. To build on these findings, the team intends to launch a prospective study to further demonstrate Signatera’s clinical utility and explore its role in informing treatment decisions and improving future sarcoma care.

About Signatera

Signatera is a personalized, tumor-informed, molecular residual disease test for patients previously diagnosed with cancer. Custom-built for each individual, Signatera uses circulating tumor DNA to detect and quantify cancer left in the body, identify recurrence earlier than standard of care tools, and help optimize treatment decisions. The test is available for clinical and research use and has coverage by Medicare across a broad range of indications. Signatera has been clinically validated across multiple cancer types and indications, with published evidence in more than 100 peer-reviewed papers.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 250 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

Forward-Looking Statements

All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera’s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera’s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy, and performance of our tests, or of the benefits of our tests and product offerings to patients, providers, and payers. Additional risks and uncertainties are discussed in greater detail in “Risk Factors” in Natera’s recent filings on Forms 10-K and 10-Q, and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.

References

  1. Moffitt Cancer Center. What Are the Different Types of Sarcoma? Moffitt Cancer Center, https://www.moffitt.org/cancers/sarcoma/faqs/what-are-the-different-types-of-sarcoma/. Accessed March 31, 2025.
  2. Sarcoma Alliance. (n.d.). What is sarcoma? Sarcoma Alliance. Retrieved April 28, 2025, from https://sarcomaalliance.org/what-is-sarcoma/

Investor Relations: Mike Brophy, CFO, Natera, Inc., [email protected]

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., [email protected]

KEYWORDS: United States North America California Texas

INDUSTRY KEYWORDS: Research Genetics Clinical Trials Biotechnology Health University Science Education Oncology

MEDIA:

Logo
Logo

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

Board expansion reflects Company’s commitment to leadership and innovation in remote cardiac monitoring

SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced the appointment of Chief Executive Officer, Robert Eno, to its Board of Directors. As the Company continues to make significant advancements towards commercial readiness, the Board elected to expand from eight to nine members to accommodate this addition.

Mr. Eno joined HeartBeam as President in January 2023 and was appointed CEO in October 2024. With over 30 years of experience in the medical technology industry, he has a proven track record of developing markets and launching disruptive medical technologies. His leadership has been instrumental as HeartBeam prepares to commercialize its groundbreaking 3D ECG technology, which captures the heart’s electrical signals in 3 non-coplanar directions and then synthesizes these signals into a 12-lead ECG.

Rich Ferrari, Executive Chairman, Board of Directors of HeartBeam, commented, “Rob’s deep expertise in sales and go-to-market strategies perfectly complements the diverse skillset and experience of the Board and strengthens our strategic oversight as we move toward commercialization and long-term growth. We are confident that Rob’s perspective will be instrumental in helping HeartBeam achieve its vision of delivering powerful cardiac insights wherever the patient is.”

HeartBeam received FDA clearance for its patented 3D ECG technology in December 2024 and submitted an FDA application for the 12-lead ECG synthesis software in January 2025. The Company plans to initiate commercialization upon receiving FDA clearance for the 12-lead ECG synthesis software. Earlier this year, the Company initiated an Early Access Program to obtain important feedback on the end-to-end clinical workflow, ensure operational readiness and establish an early adopter funnel.

“I am honored to join the HeartBeam Board as we are on the brink of bringing HeartBeam’s novel technology to market,” said Mr. Eno. “I look forward to working closely with my fellow Board members as we leverage our diverse expertise to drive the Company’s commercial success and accelerate the Company’s mission to transform the way cardiac health is managed.”

Prior to joining HeartBeam, Mr. Eno served as CEO of Preview Medical, a diagnostic equipment company developing real-time, in vivo tissue classification for solid tumor cancers using machine learning and proprietary optical signals. He also held senior marketing and sales leadership roles at companies including HeartFlow, OptiMedica, NeoGuide Systems, and Avantec Vascular. Mr. Eno holds an MBA from the Stanford Graduate School of Business and a BA, with Honors and Distinction, from Stanford University.​

About HeartBeam, Inc.

HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first ever cable-free device capable of collecting ECG signals in 3D, from 3 non-co-planar directions, and synthesizes the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024. The Company holds 14 U.S. and 4 international issued patents related to technology enablement. For additional information, visit HeartBeam.com.

Forward-Looking Statements

All statements in this release that are not based on historical fact are “forward-looking statements.” While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our Forms 10-K, 10-Q and other reports filed with the SEC and available at www.sec.gov. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Investor Relations Contact:

Chris Tyson 

Executive Vice President

MZ North America

Direct: 949-491-8235

[email protected]

www.mzgroup.us

Media Contact:

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: General Health Health Cardiology Medical Devices

MEDIA:

Logo
Logo

Welcome Home: Vivint Debuts New Brand Identity, Signaling a New Era in Smart Home

Welcome Home: Vivint Debuts New Brand Identity, Signaling a New Era in Smart Home

The evolved identity reflects the brand’s mission to empower homeowners to live in the moment through smarter security and smarter energy management, all in one place

LEHI, Utah–(BUSINESS WIRE)–
Over the past 25 years, Vivint has grown from a singular focus on home security to pioneering an integrated smart home experience with security at its core. Today’s unveiling of a new visual identity represents both an evolution and expansion of that focus, redefining a truly smarter home experience to include smarter energy management.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505557305/en/

The logo is thoughtfully designed and crafted to reflect Vivint’s brand personality and the future of smarter home. Rounded elements & terminals portray human and approachable, while squared terminals and linear components signal thoughtful and precise.

The logo is thoughtfully designed and crafted to reflect Vivint’s brand personality and the future of smarter home. Rounded elements & terminals portray human and approachable, while squared terminals and linear components signal thoughtful and precise.

Vivint has earned the trust of millions of customers throughout the U.S. by making it easy to secure, automate and control their homes through a single app experience. The brand’s award-winning security products, along with the ability to connect various smart devices to the Vivint system—including thermostats, lighting, and locks—have earned Vivint accolades as the best all-in-one security and smart home platform in the industry. It’s from this position that Vivint, now part of NRG (NYSE: NRG), is uniquely able to usher in the era of smarter homes.

“We are entering a rapid phase of innovation, where energy management concerns are beginning to rival security concerns,” said David Porter, Managing Director of Vivint. “As part of NRG and under new leadership, Vivint is poised to lead this phase and redefine the smart home experience like no one else can. By integrating security and energy management, and making it accessible to millions more homes, we’re at the start of an exciting new chapter for our customers and for Vivint.”

Building upon a quarter-century of smarter, safer homes

Launched in 1999 as a home security solution provider, the company expanded into proprietary smart home and automation services in 2011, marking the transformation with a new name – Vivint. A combination of “vive,” which means “to live,” and “intelligent,” the name exemplified a new dedication to helping customers live safely, intelligently and in harmony with their home and lifestyle.

With an average customer tenure of nine years and over 2 million customers in the U.S., Vivint was acquired by NRG, a Fortune 500 energy and home services company, in March of 2023. Known for delivering award-winning customer service, NRG brings innovative, smart energy solutions to millions of homes and businesses in the U.S. and Canada. The company’s recent consumer research found that nearly 70% of people want an “all-in-one’ unified smart home management system inclusive of energy management.

As part of NRG, Vivint has been able to accelerate its efforts to make this a reality. Recently, Reliant, also an NRG company, announced the Smarter Home Bundle, a joint offer from Vivint and Reliant that enables customers to start their smarter home journey. Qualifying current and new Reliant customers receive a free Vivint Doorbell Camera Pro and Vivint Smart Thermostat paired with complimentary white-glove installation to ensure everything is perfectly set up from day one. Reliant customers enrolled in the Smarter Home Bundle will also have access to an exclusive Vivint app experience that provides personalized energy insights powered by Reliant alongside seamless control of Vivint smart home devices – all in one place.

A new look for a trusted partner

Vivint’s brand updates include a new logo thoughtfully crafted to emphasize the focus on the home and what it means to live intelligently. The wordmark carries the familiarity of the prior identity but with a more approachable and human touch, and the new home icon conveys the idea of intelligence coming into the home and represents the brand’s unique approach that has brought peace of mind for millions of families. Together, they create a more ownable identity that captures the essence of what it feels like to live in a smarter home.

The company’s refreshed color scheme also reflects that same shift while remaining true to the iconic palette that has become a staple in the yards and homes of millions of Americans. These colors not only shape the brand’s visual identity but serve an important functional purpose within the Vivint system and are prevalent in the products and app experience. The full palette evokes growth, vision, and optimism while creating a warm, inviting, and gentle vibe that makes people feel welcome and at ease.

Unchanged with the new brand identity is the company’s commitment to white-glove professional installation and service, award-winning customer support and monitoring, and end-to-end control of its products, systems, and customer experiences.

About Vivint

Vivint, an NRG company, is a leading U.S. smart home company redefining the home experience through intelligent products and services that help millions of customers live in smarter, safer, more efficient homes. Vivint’s integrated platform combines security, energy management, and automation, delivering a fully connected experience with a human touch that offers customers greater control of homes, anytime, from anywhere. Every Vivint system includes professional installation and personalized setup from Vivint home experts, plus award-winning 24/7 customer support and monitoring. For more information, visit https://www.vivint.com.

Media:

Mark Delcorps

Vivint PR

[email protected]

KEYWORDS: United States North America Utah

INDUSTRY KEYWORDS: Hardware Residential Building & Real Estate Construction & Property Consumer Electronics Technology Finance Other Consumer Professional Services Women Men Other Technology Family Interior Design Consumer Internet Other Construction & Property

MEDIA:

Photo
Photo
The logo is thoughtfully designed and crafted to reflect Vivint’s brand personality and the future of smarter home. Rounded elements & terminals portray human and approachable, while squared terminals and linear components signal thoughtful and precise.
Photo
Photo
From smart cameras and sensors to thermostats, lighting, and more, Vivint delivers a fully connected experience that gives customers greater control of their smart homes, anytime, from anywhere. Every system includes professional installation and personalized setup from Vivint home experts, plus award-winning 24/7 customer support and monitoring.
Photo
Photo
A refreshed color palette conveys growth and optimism while recognizing the brand’s unique heritage. Two of the six new colors, ‘visionary green’ and ‘confident orange,’ stand out in this regard. Both colors serve an important functional purpose within the Vivint system and are prevalent in the products and app experience.
Photo
Photo
Vivint was acquired by NRG in March of 2023. As part of NRG, Vivint is uniquely positioned to accelerate its growth and bring smarter energy management into the smart home ecosystem.
Photo
Photo
Reliant, also an NRG company, recently announced the Smarter Home Bundle, an offer for qualifying Reliant customers that includes a free Vivint Doorbell Camera Pro and Vivint Smart Thermostat paired with complimentary installation. Smarter Home Bundle customers gain access to an exclusive Vivint app experience that provides personalized energy insights.
Logo
Logo

Angel Oak Mortgage REIT, Inc. Reports First Quarter 2025 Financial Results

Angel Oak Mortgage REIT, Inc. Reports First Quarter 2025 Financial Results

ATLANTA–(BUSINESS WIRE)–Angel Oak Mortgage REIT, Inc. (NYSE: AOMR) (the “Company,” “we,” and “our”),a leading real estate finance company focused on acquiring and investing in first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market, today reported financial results for the quarter ended March 31, 2025.

First Quarter 2025 Highlights

  • Q1 2025 GAAP net income of $20.5 million, or $0.87 per diluted share of common stock.
  • Q1 2025 net interest income of $10.1 million demonstrates an increase of 17.6% versus Q1 2024 net interest income of $8.6 million and an increase of 2.3% versus Q4 2024 net interest income.
  • Q1 2025 GAAP book value of $10.70 per share and economic book value of $13.41 per share, increases of 5.2% and 2.4%, respectively, compared to the end of 2024.
  • Q1 2025 Distributable Earnings of $4.1 million, or $0.17 per diluted share of common stock.
  • Declared a dividend of $0.32 per share of common stock, which will be paid on May 30, 2025, to common stockholders of record as of May 22, 2025.

Sreeni Prabhu, Chief Executive Officer and President of Angel Oak Mortgage REIT, Inc., said “We are proud to have achieved continued net interest income expansion in the first quarter of this year, marking approximately 18% growth compared to the first quarter of 2024 and over 2% growth compared to the fourth quarter of 2024. Our earnings growth was buoyed by the acquisition of nearly $260 million of high-quality non-QM loan purchases throughout the first quarter along with continued maintenance of our operating expense savings. Despite recent volatility caused by broad uncertainty around tariffs, we look to continue expanding earnings through additional loan purchases with the capital made available by our post-quarter end securitization. And, as always, we will remain committed to growing long-term shareholder value through disciplined risk management, securitization execution, and strategic capital deployment.”

Portfolio and Investment Activity

  • Following quarter end, in April 2025, the Company executed the AOMT 2025-4 securitization as the sole contributor of loans. The Company contributed loans with a scheduled unpaid principal balance of approximately $284.3 million and a 7.50% weighted average coupon. This securitization reduced the Company’s debt by approximately $242.4 million and released cash of $24.7 million to the Company, which was used for new loan purchases and operational purposes, including paying down a portion of repurchase debt obligation on our retained bond positions, and general corporate purposes.
  • During the quarter, the Company purchased $259.0 million of newly-originated, current market coupon non-QM residential mortgage loans, with a weighted average coupon of 7.67%, weighted average loan-to-value ratio (“LTV”) of 70.0% and weighted average credit score of 751.
  • As of March 31, 2025, the weighted average coupon of our residential whole loans portfolio was 7.55%, marking a 44 basis point increase compared to March 31, 2024.

Capital Markets Activity

As of March 31, 2025, the Company was a party to three loan financing lines which permit borrowings in an aggregate amount of up to $1.1 billion, of which approximately $360 million is drawn, leaving capacity of approximately $690 million for new loan purchases.

Balance Sheet

  • Target assets totaled $2.5 billion as of March 31, 2025.
  • The Company held residential mortgage whole loans with fair value of $439.5 million as of March 31, 2025.
  • As of March 31, 2025, the Company’s recourse debt to equity ratio was approximately 2.3x.

    • Subsequent to quarter end, the Company used the proceeds of the AOMT 2025-4 securitization to pay down $242.4 million of debt and replaced it with non-recourse leverage, reducing the Company’s recourse debt to equity ratio to approximately 1.3x.

Dividend

On May 5, 2025, the Company declared a dividend of $0.32 per share of common stock, which will be paid on May 30, 2025, to common stockholders of record as of May 22, 2025.

Conference Call and Webcast Information

The Company will host a live conference call and webcast today, May 5, 2025 at 8:30 a.m. Eastern time. To listen to the live webcast, go to the Investors section of the Company’s website at www.angeloakreit.com at least 15 minutes prior to the scheduled start time in order to register and install any necessary audio software.

To Participate in the Telephone Conference Call:

Dial in at least 15 minutes prior to start time.

Domestic: 1-844-826-3033

International: 1-412-317-5185

Conference Call Playback:

Domestic: 1-844-512-2921

International: 1-412-317-6671

Pass code: 10198623

The playback can be accessed through May 19, 2025.

Non-GAAP Metrics

Distributable Earnings is a non‑GAAP measure and is defined as net income (loss) allocable to common stockholders as calculated in accordance with generally accepted accounting principles in the United States of America (“GAAP”), excluding (1) unrealized gains and losses on our aggregate portfolio, (2) impairment losses, (3) extinguishment of debt, (4) non-cash equity compensation expense, (5) the incentive fee earned by Falcons I, LLC, our external manager (our “Manager”), (6) realized gains or losses on swap terminations and (7) certain other nonrecurring gains or losses. We believe that the presentation of Distributable Earnings provides investors with a useful measure to facilitate comparisons of financial performance among our real estate investment trust (“REIT”) peers, but has important limitations. We believe Distributable Earnings as described above helps evaluate our financial performance without the impact of certain transactions but is of limited usefulness as an analytical tool. Therefore, Distributable Earnings should not be viewed in isolation and is not a substitute for net income computed in accordance with GAAP. Our methodology for calculating Distributable Earnings may differ from the methodologies employed by other REITs to calculate the same or similar supplemental performance measures, and as a result, our Distributable Earnings may not be comparable to similar measures presented by other REITs.

Distributable Earnings Return on Average Equity is a non-GAAP measure and is defined as annual or annualized Distributable Earnings divided by average total stockholders’ equity. We believe that the presentation of Distributable Earnings Return on Average Equity provides investors with a useful measure to facilitate comparisons of financial performance among our REIT peers, but has important limitations. Additionally, we believe Distributable Earnings Return on Average Equity provides investors with additional detail on the Distributable Earnings generated by our invested equity capital. We believe Distributable Earnings Return on Average Equity as described above helps evaluate our financial performance without the impact of certain transactions but is of limited usefulness as an analytical tool. Therefore, Distributable Earnings Return on Average Equity should not be viewed in isolation and is not a substitute for net income computed in accordance with GAAP. Our methodology for calculating Distributable Earnings Return on Average Equity may differ from the methodologies employed by other REITs to calculate the same or similar supplemental performance measures, and as a result, our Distributable Earnings Return on Average Equity may not be comparable to similar measures presented by other REITs.

Economic book value is a non-GAAP financial measure of our financial position. To calculate our economic book value, the portions of our non-recourse financing obligation held at amortized cost are adjusted to fair value. These adjustments are also reflected in our end of period total stockholders’ equity. Management considers economic book value to provide investors with a useful supplemental measure to evaluate our financial position as it reflects the impact of fair value changes for our legally held retained bonds, irrespective of the accounting model applied for GAAP reporting purposes. Economic book value does not represent and should not be considered as a substitute for book value per share of common stock or stockholders’ equity, as determined in accordance with GAAP, and our calculation of this measure may not be comparable to similarly titled measures reported by other companies.

Forward-Looking Statements

This press release contains certain forward-looking statements that are subject to various risks and uncertainties, including, without limitation, statements relating to the performance of the Company’s investments. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “may,” “will,” “should,” “potential,” “intend,” “expect,” “endeavor,” “seek,” “anticipate,” “estimate,” “believe,” “could,” “project,” “predict,” “continue,” or by the negative of these words and phrases or other similar words or expressions. Forward-looking statements are based on certain assumptions, discuss future expectations, describe existing or future plans and strategies, contain projections of results of operations, liquidity and/or financial condition, or state other forward-looking information. The Company’s ability to predict future events or conditions or their impact or the actual effect of existing or future plans or strategies is inherently uncertain. Although the Company believes that such forward-looking statements are based on reasonable assumptions, actual results and performance in the future could differ materially from those set forth in or implied by such forward-looking statements. You are cautioned not to place undue reliance on these forward‐looking statements, which reflect the Company’s views only as of the date of this press release. Additional information concerning factors that could cause actual results and performance to differ materially from these forward-looking statements is contained from time to time in the Company’s filings with the Securities and Exchange Commission. Except as required by applicable law, neither the Company nor any other person assumes responsibility for the accuracy and completeness of the forward‐looking statements. The Company does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Angel Oak Mortgage REIT, Inc.

Angel Oak Mortgage REIT, Inc. is a real estate finance company focused on acquiring and investing in first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. The Company’s objective is to generate attractive risk-adjusted returns for its stockholders through cash distributions and capital appreciation across interest rate and credit cycles. The Company is externally managed and advised by an affiliate of Angel Oak Capital Advisors, LLC, which, collectively with its affiliates, is a leading alternative credit manager with market leadership in mortgage credit that includes asset management, lending, and capital markets. Additional information about the Company is available at www.angeloakreit.com

Angel Oak Mortgage REIT, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(Unaudited)

(in thousands, except for share and per share data)

 

 

Three Months Ended

 

March 31, 2025

 

March 31, 2024

INTEREST INCOME, NET

 

 

 

Interest income

$

32,867

 

 

$

25,212

 

Interest expense

 

22,780

 

 

 

16,633

 

NET INTEREST INCOME

$

10,087

 

 

$

8,579

 

 

 

 

 

REALIZED AND UNREALIZED GAINS (LOSSES), NET

 

 

 

Net realized gain (loss) on mortgage loans, derivative contracts, RMBS, and CMBS

$

(3,182

)

 

$

(1,422

)

Net unrealized gain (loss) on trading securities, mortgage loans, portion of debt at fair value option, and derivative contracts

 

16,625

 

 

 

10,684

 

TOTAL REALIZED AND UNREALIZED GAINS (LOSSES), NET

$

13,443

 

 

$

9,262

 

 

 

 

 

EXPENSES

 

 

 

Operating expenses

$

1,201

 

 

$

2,048

 

Operating expenses incurred with affiliate

 

416

 

 

 

515

 

Stock compensation

 

237

 

 

 

630

 

Securitization costs

 

 

 

 

174

 

Management fee incurred with affiliate

 

1,145

 

 

 

1,313

 

Total operating expenses

$

2,999

 

 

$

4,680

 

 

 

 

 

INCOME (LOSS) BEFORE INCOME TAXES

$

20,531

 

 

$

13,161

 

Income tax expense

 

 

 

 

287

 

NET INCOME (LOSS) ALLOCABLE TO COMMON STOCKHOLDERS

$

20,531

 

 

$

12,874

 

Other comprehensive income (loss)

 

(695

)

 

 

1,703

 

TOTAL COMPREHENSIVE INCOME (LOSS)

$

19,836

 

 

$

14,577

 

 

 

 

 

Basic earnings (loss) per common share

$

0.88

 

 

$

0.52

 

Diluted earnings (loss) per common share

$

0.87

 

 

$

0.51

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

Basic

 

23,396,151

 

 

 

24,775,815

 

Diluted

 

23,644,598

 

 

 

24,965,274

 

Angel Oak Mortgage REIT, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(in thousands, except for share and per share data)

 

 

As of:

 

March 31, 2025

 

December 31, 2024

ASSETS

 

 

 

Residential mortgage loans – at fair value

$

439,460

 

 

$

183,064

 

Residential mortgage loans in securitization trusts – at fair value

 

1,672,189

 

 

 

1,696,995

 

RMBS – at fair value

 

398,272

 

 

 

300,243

 

U.S. Treasury securities – at fair value

 

74,959

 

 

 

 

Cash and cash equivalents

 

38,696

 

 

 

40,762

 

Restricted cash

 

4,774

 

 

 

2,131

 

Principal and interest receivable

 

9,823

 

 

 

8,141

 

TBA derivatives and interest rate futures derivatives – at fair value

 

1,421

 

 

 

1,515

 

Other assets

 

36,941

 

 

 

36,918

 

Total assets

$

2,676,535

 

 

$

2,269,769

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

LIABILITIES

 

 

 

Notes payable

$

360,470

 

 

$

129,459

 

Non-recourse securitization obligation, collateralized by residential mortgage loans in securitization trusts (see Note 2)

 

1,556,075

 

 

 

1,593,612

 

Securities sold under agreements to repurchase

 

148,467

 

 

 

50,555

 

Interest rate futures derivatives – at fair value

 

947

 

 

 

 

Due to broker

 

302,619

 

 

 

201,994

 

Senior unsecured notes

 

47,865

 

 

 

47,740

 

Accrued expenses

 

2,539

 

 

 

2,291

 

Accrued expenses payable to affiliate

 

248

 

 

 

766

 

Interest payable

 

1,865

 

 

 

934

 

Income taxes payable

 

2,785

 

 

 

2,785

 

Management fee payable to affiliate

 

1,175

 

 

 

666

 

Total liabilities

$

2,425,055

 

 

$

2,030,802

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY

 

 

 

Common stock, $0.01 par value. As of March 31, 2025: 350,000,000 shares authorized, 23,500,175 shares issued and outstanding. As of December 31, 2024: 350,000,000 shares authorized, 23,500,175 shares issued and outstanding.

$

234

 

 

$

234

 

Additional paid-in capital

 

461,294

 

 

 

461,057

 

Accumulated other comprehensive income (loss)

 

(4,170

)

 

 

(3,475

)

Retained earnings (deficit)

 

(205,878

)

 

 

(218,849

)

Total stockholders’ equity

$

251,480

 

 

$

238,967

 

Total liabilities and stockholders’ equity

$

2,676,535

 

 

$

2,269,769

 

Angel Oak Mortgage REIT, Inc.

Reconciliation of Net Income (Loss) to Distributable Earnings

and Distributable Earnings Return on Average Equity

(Unaudited)

 

 

Three Months Ended

 

March 31, 2025

 

March 31, 2024

 

(in thousands)

Net income (loss) allocable to common stockholders

$

20,531

 

 

$

12,874

 

Adjustments:

 

 

 

Net unrealized (gains) losses on trading securities

 

1,032

 

 

 

1

 

Net unrealized (gains) losses on derivatives

 

1,042

 

 

 

(445

)

Net unrealized (gains) losses on residential loans in securitization trusts and non-recourse securitization obligation

 

(15,657

)

 

 

(5,147

)

Net unrealized (gains) losses on residential loans

 

(3,041

)

 

 

(5,071

)

Net unrealized (gains) losses on commercial loans

 

 

 

 

(22

)

Stock compensation

 

237

 

 

 

630

 

Distributable Earnings

$

4,144

 

 

$

2,820

 

 

Three Months Ended

 

March 31, 2025

 

March 31, 2024

 

($ in thousands)

Annualized Distributable Earnings

$

16,576

 

 

$

11,280

 

Average total stockholders’ equity

 

252,033

 

 

 

259,715

 

Distributable Earnings Return on Average Equity

 

6.6

%

 

 

4.3

%

Angel Oak Mortgage REIT, Inc.

Reconciliation of Stockholders’ Equity to Stockholders’ Equity Including Economic Book Value Adjustments

and Economic Book Value per Share of Common Stock

(Unaudited)

 

 

March 31,

2025

 

December 31, 2024

 

September 30, 2024

 

June 30,

2024

 

March 31,

2024

 

(in thousands, except for share and per share data)

GAAP total stockholders’ equity

$

251,480

 

$

238,967

 

$

265,098

 

$

255,806

 

$

263,324

Adjustments:

 

 

 

 

 

 

 

 

 

Fair value adjustment for securitized debt held at amortized cost

 

63,593

 

 

68,784

 

 

64,522

 

 

73,053

 

 

80,599

Stockholders’ equity including economic book value adjustments

$

315,073

 

$

307,751

 

$

329,620

 

$

328,859

 

$

343,923

 

 

 

 

 

 

 

 

 

 

Number of shares of common stock outstanding at period end

 

23,500,175

 

 

23,500,175

 

 

23,511,272

 

 

24,998,549

 

 

24,965,274

Book value per share of common stock

$

10.70

 

$

10.17

 

$

11.28

 

$

10.23

 

$

10.55

Economic book value per share of common stock

$

13.41

 

$

13.10

 

$

14.02

 

$

13.16

 

$

13.78

 

Investors:

[email protected]

855-502-3920

IR Agency Contact:

Nick Teves or Joseph Caminiti, Alpha IR Group

312-445-2870

[email protected]

Company Contact:

KC Kelleher, Head of Corporate Finance & Investor Relations

404-528-2684

[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: REIT Finance Professional Services Residential Building & Real Estate Construction & Property

MEDIA:

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, May 12, 2025, at 4:30 p.m. E.T., to discuss its first quarter 2025 financial results.

Quanterix will issue a press release regarding its first quarter 2025 financial results prior to the conference call on Monday, May 12, 2025, after the market closes. The press release will be posted on the Quanterix website at https://www.quanterix.com/.

To listen to the live conference call, investors can dial (800) 715-9871 or (646) 307-1963 and enter conference ID 7353673. Interested investors can also access the live webcast from the News & Events page within the Investors section of the Quanterix website at http://www.quanterix.com. An archived webcast replay will be available on the Company’s website for one year.

About Quanterix

From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 3,200 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com or follow us on Twitter and LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release are based on Quanterix’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Quanterix’ filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

Media Contact:

Marissa Klaassen

(978) 488-1854

[email protected]

Investor Relations Contact:

Joshua Young

(508) 846-3327

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Medical Devices Infectious Diseases Neurology Cardiology Biotechnology Other Health Health Pharmaceutical Oncology

MEDIA:

monday.com Announces Participation in the J.P. Morgan Global Technology, Media and Communications Conference

monday.com Announces Participation in the J.P. Morgan Global Technology, Media and Communications Conference

NEW YORK & TEL AVIV, Israel–(BUSINESS WIRE)–
monday.com (NASDAQ: MNDY), the global software company that transforms how businesses run, today announced that members of its management team will participate in the J.P. Morgan Global Technology, Media and Communications Conference on Wednesday, May 14, 2025 at 1:40 pm ET.

The presentation will cover recent events in a fireside chat format and will be webcast live on monday.com’s investor relations website at http://ir.monday.com. A replay of the presentation will be made available on the website under the News and Events section.

About monday.com:

monday.com is a global software company that transforms how businesses run. Our product suite can adapt to the needs of diverse industries and use cases within one powerful platform. Our ~245,000 customers are reimagining how work gets done, driving greater efficiency, and scaling like never before. For more information, visit monday.com.

Investor Relations:

Byron Stephen

[email protected]

Media Relations:

Julie Case

[email protected]

KEYWORDS: United States North America Israel Middle East New York

INDUSTRY KEYWORDS: Technology Mobile/Wireless Audio/Video Other Technology Telecommunications Software Networks Internet Hardware Electronic Design Automation Data Management Security Consumer Electronics VoIP

MEDIA:

Logo
Logo

Local Snapshot: Half Of U.S. Small Businesses Change Strategies Amid Macro-Economic Challenges, Chase Survey Finds

Local Snapshot: Half Of U.S. Small Businesses Change Strategies Amid Macro-Economic Challenges, Chase Survey Finds

Despite continued uncertainty, small business owners in key markets are strategically investing in their operations to adapt and future-proof

NEW YORK–(BUSINESS WIRE)–
Half of U.S small business owners have changed how they run their businesses as economic pressures continue, a new Chase survey reveals. Between inflationary challenges, hiring shortages and tariffs, small business sentiment remains well-below post-election highs. Yet, instead of retreating, many businesses are taking action to adapt and innovate, particularly in key markets across the country.

Conducted nationally, with in-depth analyses in Boston, Chicago, Houston, San Diego, Seattle and Tampa, the Chase survey reveals that despite a challenging environment, 41% of small businesses nationally identify as being in “growth mode”. These businesses are actively working to increase sales, looking to expand to new locations, and hiring more staff.

They’re also investing in technology – like digital payments and payroll software –prioritizing employee retention, and adapting their supply chains, resulting in revenue increases that exceed expectations. This proactive approach is particularly evident in cities like Chicago, Seattle, and Houston, where growth mode percentages are even higher at 70%, 58%, and 56%, respectively.

“Market conditions and overall optimism will always fluctuate, but what matters is how businesses respond and adapt to the moment,” said Ben Walter, CEO, Chase for Business. “Small business owners are some of the most resilient and forward-thinking leaders out there – constantly adopting new tools and navigating challenging times with grit and innovation.”

When surveying select markets across the country, the data found that these small business owners were 1.4 times more likely to buy local and integrate AI tools, and 1.3 times more likely to invest in employee retention compared to the national average. According to the survey, these growing small businesses are:

Bolstering cash buffers amid elevated uncertainty, while paying down existing debt

  • 18% of small businesses in these metro areas are either increasing extra cash on hand or planning to in the next month. These trends were most notable in San Diego (24%) and Boston (20%).
  • 27% of small businesses in these markets are currently paying down debts or planning to within the next month – particularly in Boston (32%) and Chicago (30%).

Integrating AI and digital technology, underscoring a commitment to innovation and operational efficiency

  • 40% of Boston and San Diego small businesses have adopted AI tools, followed by Tampa (38%) and Seattle (34%).
  • These businesses are 1.5 times more likely to say that digital transformation has been crucial to their post-pandemic success.

Continuing to invest in their business resulting in better-than-expected revenues

  • 71% of businesses in these markets are experiencing rising revenues, compared with the national average (54%). 78% of businesses in Boston note better than expected business results, followed by Chicago (76%) and Houston (70%).
  • Over 90% of respondents in Chicago and Tampa say that it is important to invest in the business during challenging market conditions.

You can download a detailed snapshot of these findings HERE.

ABOUT THE SURVEY

Chase surveyed approximately 500 small business owners across the nation, and an additional ~300 in six specific metro areas in mid-March 2025. Respondents include both Chase and non-Chase customers. The markets selected were based on a number of factors including having a dynamic business environment, a known culture of innovation and entrepreneurship, and a strong Chase for Business presence. These markets were also more likely to say that they their business is under five years old compared with the national average (53% MSA average vs 38% national).

About Chase

Chase is the U.S. consumer and commercial banking business of JPMorgan Chase & Co. (NYSE: JPM), a leading financial services firm based in the United States of America with assets of $4.4 trillion and operations worldwide. Chase serves more than 84 million consumers and 7 million small businesses, with a broad range of financial services, including personal banking, credit cards, mortgages, auto financing, investment advice, small business loans and payment processing. Customers can choose how and where they want to bank: Nearly 5,000 branches in 48 states and the District of Columbia, more than 15,000 ATMs, mobile, online and by phone. For more information, go to chase.com.

Elizabeth Seymour

[email protected]

Chaffon Davis

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo